Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Aerovate Therapeutics, Inc. (AVTE) has announced a merger agreement with Jade Biosciences, a biotech spinout of Paragon. Following the announcement, AVTE shares experienced a pre-market increase of 23.3%. However, the merger has drawn scrutiny, with Halper Sadeh LLC investigating whether the terms of the merger are fair to shareholders. Additionally, Ademi LLP is also looking into whether Aerovate is obtaining a fair price for its public shareholders. The stock was halted prior to the announcement of the merger.
MPB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Mid Penn Bancorp, Inc. Is Fair to Shareholders https://t.co/vynlQOg1FM https://t.co/R9d8cZd7l4
Shareholder Alert: Ademi LLP Investigates Whether William Penn Bancorporation Is Obtaining a Fair Price for Its Public Shareholders https://t.co/eWu5hRswFr https://t.co/OO4expkZ9s
WMPN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of William Penn Bancorporation Is Fair to Shareholders https://t.co/WuvtIs7OvG https://t.co/hQoMzoo97i
